Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$690,350
-$19,158 QoQ
Shares Held
1,546
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WEALTH ALLIANCE, LLC holds $2,021,887 across 7 Biotechnology names. VRTX ranks #1 (34.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,546 | $690,350 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
485 | $374,730 | |
| 3 | GMAB |
Genmab A/S
|
13,615 | $365,290 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,016 | $336,163 | |
| 5 | INSM |
INSMED Inc
|
1,421 | $232,361 | |
| 6 | TLSA |
Tiziana Life Sciences Ltd
|
10,350 | $12,109 | |
| 7 | BRTX |
BioRestorative Therapies, Inc.
|
40,000 | $10,884 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $690,350 | 1,546 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $709,508 | 1,565 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $493,074 | 1,259 | Shares | Defined | 2025-11-07 | |
| 2023-12-31 | $214,024 | 526 | Shares | Defined | 2024-01-30 | |
| No filing history on record for this holder in this stock. | ||||||